Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Melanoma 4Carcinoma, Renal Cell 4Carcinoma, Non-Small-Cell Lung 4Carcinoma, Hepatocellular 3Various Advanced Cancer 2Stomach Neoplasms 2Esophageal Neoplasms 2Colorectal Neoplasms 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urothelial Cancer 1Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Rectal Neoplasms 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neoplasms 1Multiple Myeloma 1Microsatellite Unstable Colorectal Cancer 1Mesothelioma 1Lymphoma 1Lung Neoplasms 1Hodgkin Disease 1Hematologic Neoplasms 1Glioma 1Endometrial Neoplasms 1Colonic Neoplasms 1Breast Neoplasms 1Advanced or Metastatic Solid Tumors 1

Interventions

Oxaliplatin 1Nivolumab 1Leucovorin 1Ipilimumab 1Fluorouracil 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has announcements × Adenocarcinoma Of Esophagus × Nivolumab × Clear all
NCT02872116 2025-08-07

CheckMate649

Bristol-Myers Squibb

Phase 3 Completed
2,031 enrolled 19 charts 1 FDA
Gastrointestinal

Adenocarcinoma Of Esophagus, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡